CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
-6.34%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$107M
AUM Growth
+$107M
(-4.4%)
Cap. Flow
+$362K
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
84.05%
Holding
19
New
4
Increased
5
Reduced
7
Closed
3
Top Buys
| 1 |
AbbVie
ABBV
|
$10M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$9.17M |
| 3 |
Centene
CNC
|
$6.36M |
| 4 |
IQVIA
IQV
|
$4.78M |
| 5 |
Gilead Sciences
GILD
|
$3.17M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$5.88M |
| 2 |
Merck
MRK
|
$5.64M |
| 3 |
Illumina
ILMN
|
$5.48M |
| 4 |
Sarepta Therapeutics
SRPT
|
$4.56M |
| 5 |
Stryker
SYK
|
$3.82M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $12.5M | 11.67% |
197,916
+50,000
| +34% | +$3.17M |
|
2
Vertex Pharmaceuticals
VRTX
$100B
| $11M | 10.22% |
64,849
-6,000
| -8% | -$1.02M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $10M | 9.34% |
197,937
-45,000
| -19% | -$2.28M |
|
|
4
AbbVie
ABBV
$372B
| $10M | 9.3% |
+132,000
| New | +$10M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $9.17M | 8.53% |
+136,000
| New | +$9.17M |
|
|
6
IQVIA
IQV
$32.4B
| $8.66M | 8.06% |
57,986
+32,000
| +123% | +$4.78M |
|
7
Thermo Fisher Scientific
TMO
$186B
| $8.44M | 7.85% |
28,976
-7,000
| -19% | -$2.04M |
|
8
Humana
HUM
$36.5B
| $7.93M | 7.37% |
31,000
-10,000
| -24% | -$2.56M |
|
|
9
Centene
CNC
$14.3B
| $6.36M | 5.92% |
+147,000
| New | +$6.36M |
|
|
10
Merck
MRK
$210B
| $6.23M | 5.8% |
74,000
-67,000
| -48% | -$5.64M |
|
11
CareDx
CDNA
$727M
| $4.18M | 3.89% |
184,855
+55,000
| +42% | +$1.24M |
|
12
Zoetis
ZTS
$69.3B
| $3.78M | 3.52% |
30,375
-20,000
| -40% | -$2.49M |
|
|
13
Illumina
ILMN
$15.8B
| $2.83M | 2.64% |
9,316
-18,000
| -66% | -$5.48M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $2.69M | 2.5% |
335,000
+10,000
| +3% | +$80.2K |
|
|
SIEN
15
DELISTED
Sientra, Inc.
SIEN
| $2.5M | 2.32% |
385,000
+25,000
| +7% | +$162K |
|
16
Fate Therapeutics
FATE
$120M
| $1.17M | 1.08% |
+75,000
| New | +$1.17M |
|
|
17
Intuitive Surgical
ISRG
$170B
| – | – |
-11,201
| Closed | -$5.88M |
|
|
18
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-30,000
| Closed | -$4.56M |
|
|
19
Stryker
SYK
$150B
| – | – |
-18,597
| Closed | -$3.82M |
|